Delving into the Latest Updates on SunGlow Lifescience Pvt Ltd. with Synapse

概览

关联

8

项与 SunGlow Lifescience Pvt Ltd. 相关的临床试验

CTRI/2024/07/071741 / Not yet recruitingN/A

An Open label, balanced, randomized, two-treatment, twoperiod, two-sequence, single dose, crossover, oral,bioequivalence study of Esomeprazole 40 mg MUPS tablets ofSunGlow Lifescience Private Ltd with Nexium mups 40 mggastro resistant tablets (Esomeprazole) of Grunenthal GmbH in healthy adult human subjects under fasting conditions. - NIL

开始日期2024-08-12

申办/合作机构

SunGlow Lifescience Pvt Ltd.

CTRI/2023/06/054073 / Not yet recruitingN/A

An open label, balanced, randomized, two-treatment, two-period, two-sequence, single oral dose, crossover, bioequivalence study of Sitagliptin 100 mg & Metformin Hydrochloride 1000 mg (extended release) Tablets of SunGlow Lifescience Private Ltd., in comparison with Janumet XR 100 mg/ 1000 mg tablets {Sitagliptin and metformin HCl (extended release) tablets 100 mg/1,000 mg} of Merck Sharp & Dohme Corp in healthy, adult, human subjects under fed conditions.

开始日期2023-06-28

申办/合作机构

SunGlow Lifescience Pvt Ltd.

[+1]

CTRI/2023/04/052085 / Active, not recruitingN/A

An open label balanced randomized two treatment two period two sequence single oral dose crossover bioequivalence study of Sitagliptin 50 mg Metformin Hydrochloride 500 mg extended release Tablets of SunGlow Lifescience Private Ltd in comparison with Janumet XR 50 mg 500 mg tablets Sitagliptin and metformin HCl extended release tablets 50 mg 500 mg of Merck Sharp Dohme Corp in healthy adult human subjects under fasting conditions

开始日期2023-04-30

申办/合作机构

SunGlow Lifescience Pvt Ltd.

100 项与 SunGlow Lifescience Pvt Ltd. 相关的临床结果

登录后查看更多信息

0 项与 SunGlow Lifescience Pvt Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 SunGlow Lifescience Pvt Ltd. 相关的药物交易

登录后查看更多信息

100 项与 SunGlow Lifescience Pvt Ltd. 相关的转化医学

登录后查看更多信息